Home/Filings/4/0001385508-23-000034
4//SEC Filing

CRYSTAL ROGER 4

Accession 0001385508-23-000034

CIK 0001385508other

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 4:22 PM ET

Size

4.8 KB

Accession

0001385508-23-000034

Insider Transaction Report

Form 4
Period: 2023-01-27
CRYSTAL ROGER
DirectorChief Executive Officer10% Owner
Transactions
  • Sale

    Common Stock

    2023-01-27$20.26/sh1,358$27,51375,339 total
Footnotes (1)
  • [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

Issuer

OPIANT PHARMACEUTICALS, INC.

CIK 0001385508

Entity typeother

Related Parties

1
  • filerCIK 0001656633

Filing Metadata

Form type
4
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:22 PM ET
Size
4.8 KB